Pregled bibliografske jedinice broj: 273236
Effect of allergen dose on airway inflammation and enhancment of airway hyperresponsiveness
Effect of allergen dose on airway inflammation and enhancment of airway hyperresponsiveness // Abstract book of 2006 NIAID, National Institute of Health, Research Conference, Opatija, Croatia, June 26-30, 2006 / ... (ur.).
Rijeka: ..., 2006. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 273236 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Effect of allergen dose on airway inflammation and enhancment of airway hyperresponsiveness
Autori
Bošnjak, Berislav ; Ferenčić, Željko ; Đurić, Koraljka ; Brajša, Karmen ; Glojnarić, Ines ; Marković, Stribor ; Antolović, Roberto ; Hrvačić, Boška
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstract book of 2006 NIAID, National Institute of Health, Research Conference, Opatija, Croatia, June 26-30, 2006
/ ... - Rijeka : ..., 2006
Skup
2006 NIAID, National Institute of Health, Research Conference,
Mjesto i datum
Opatija, Hrvatska, 26.06.2006. - 30.06.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Airway inflammation (AI); hyperresponsiveness (AHR); asthma
Sažetak
Airway inflammation (AI) and hyperresponsiveness (AHR) are two asthma hallmarks. Allergen inhalation in sensitized patients induces late-phase responses (LPR) characterized by accumulation of inflammatory cells that further enhances AHR. Therefore, allergen-induced LPR was proposed as a model for studying the pathophysiological processes occurring in asthma. As clinical investigations suggest that the dose of inhaled allergen directly influences the appearance and the severity of LPR, we intranasally challenged ovalbumin (OVA) sensitized mice with increasing OVA doses (10, 25 or 100  g OVA/mice) in order to provide new insights into the complex mechanisms by which AI enhances AHR. AHR to methacholine, measured non-invasively at its peak 24h after challenge, was increased only in mice challenged with largest OVA dose (100  g), indicating dependence of AHR on the antigen dose used for challenge. On contrary to AHR enhancement, eosinophil accumulation in bronchoalveolar lavage (BALF) and lungs 24h after challenge was almost insensitive to the OVA dose used for challenge. Interestingly, accumulation of neutrophils in BALF seems to be correlated to the OVA dose, indicating that neutrophils could play important role in AHR enhancement. However, neutrophil accumulation and AHR enhancement could be two simultaneous, but independent phenomena.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Pliva-Istraživački institut